Downregulation of estrogen-metabolizing 17β-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer development

International Journal of Cancer

Volumn 97, Issue 1, 2002, Pages 1-6

  Franco, José ^a   Pérez Hoyos, Santiago ^b   Plaza, Pedro ^c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Generalitat Valenciana   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Cell differentiation; Cell proliferation; Colon carcinoma; Estrogen; Hydroxysteroid dehydrogenase

Indexed keywords

17 OXOSTEROID; ESTROGEN; ISOENZYME; KI 67 ANTIGEN; MESSENGER RNA; MUCIN; TESTOSTERONE 17BETA DEHYDROGENASE; TUMOR MARKER;

ARTICLE; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; CRYPT CELL; DIGESTIVE SYSTEM CANCER; DOWN REGULATION; FEMALE; FETUS; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LAMINA PROPRIA; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL;

17-HYDROXYSTEROID DEHYDROGENASES; ADENOCARCINOMA; BLOTTING, NORTHERN; CELLS, CULTURED; COLONIC NEOPLASMS; DISEASE PROGRESSION; DOWN-REGULATION; ESTRADIOL; ESTRONE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; MALE; MUCINS; RNA, MESSENGER;

EID: 0036131845     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1567     Document Type: Article

References (51)

1. Large bowel cancer in women in relation to reproductive and hormonal factors: A case control study
2. Reproductive factors and colon cancer
3. Functional estrogen receptor β in colon cancer cells
4. Estrogen receptor-mediated direct stimulation of colon cancer cell growth in vitro
5. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth
6. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women
7. Molecular endocrinology of the hydroxysteroid dehydrogenases
8. 17β-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family: Nomenclature and main characteristics of the 17HSD/KSR enzymes
9. Intracrinology: Role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease
10. Characterization of 17β-hydroxysteroid dehydrogenase typel in choriocarcinoma cells: Regulation by basic fibroblast growth factor
11. Expression of 17β-hydroxysteroid dehydrogenase in human granulosa cells: Correlation with follicular size, cytochrome P-450 aromatase activity and oestradiol production
12. 17β-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue
13. 17β-hydroxysteroid dehydrogenase type 2: Chromosomal assignment and progestin regulation of gene expression in human endometrium
14. Human 17β-hydroxysteroid dehydrogenase type I and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression
15. Physiology and molecular genetics of 17β-hydoxysteroid dehydrogenases
16. Mouse 17β-hydroxysteroid dehydrogenase type 2 mRNA is predominantly expressed in hepatocytes and in surface epithelial cells of the gastrointestinal and urinary tracts
17. Human 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression and localization in term placenta and in endometrium during the menstrual cycle
18. Fundamental principles of in situ hybridization
19. Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA
20. Expression, cloning and characterization of human 17β-HSD type 2, a microsomal enzyme possessing 20α-HSD activity
21. Differential expression patterns of the PEA3 group transcription factors through murine embryonic development
22. Aberrant accumulation of p53 associates with Ki67 and mitotic count in benign skin lesions
23. Specific staining of sulfate groups with alcian blue at low pH
24. Extraction, purification, and analysis of messenger RNA from eukaryotic cells
25. Human estrogen receptor β-gene structure, chromosomal localization and expression pattern
26. 17β-hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus
27. Loss of estrogen inactivation in colonic cancer
28. Oestrogen inactivation in the colon: Analysis of the expression and regulation of 17β-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer
29. Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids
30. Peroxisomal bifunctional protein deficiency revisited: Resolution of its true enzymatic and molecular basis
31. Characterization of molecular and catalytic properties of intact and truncated human 17β-hydroxysteroid dehydrogenase type 2 enzymes: Intracellular localization of the wild-type enzyme in the endoplasmic reticulum
32. The presence of functional estrogen receptors in intestinal epithelial cells
33. Selective loss of estrogen receptor β in malignant human colon
34. Genetic alterations during colorectal tumor development
35. Mechanisms of tumor progression
36. Biomarkers of increased susceptibility to gastrointestinal cancer: New application to studies of cancer prevention in human subjects
37. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today
38. Effect of added dietary calcium on colonic epithelial cell proliferation in subjects at high-risk for familial colon cancer
39. Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody Ki-67. Relation to clinical and pathological variables
40. Mucin histochemistry in colonic polyps and cancer
41. Colonic mucin glycoprotein in health and disease
42. Colorectal mucin histochemistry in health and disease: A critical review
43. Mucus glycoproteins and their role in colorectal disease
44. Colonic mucin-carbohydrate components in colorectal tumors and their possible relationship to MUC2, p53 and DCC immunoreactivities
45. Update on gastrointestinal carcinogenesis
46. Estrogens
47. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: Relationship to carcinogenicity
48. Phyto-estrogens and western diseases
49. Clinical review 92: Phytoestrogens
50. Postmenopausal hormone use and risk of large-bowel cancer